A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

NCT06703177 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

876

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-1826
DRUG: SHR-4642
DRUG: SHR-9839
DRUG: SHR-8068
DRUG: Bevacizumab Injection
DRUG: Fluorouracil Injection
DRUG: Calcium Folinate Injection
DRUG: Adebrelimab Injection
DRUG: Capecitabine tablets

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.